Bone Biologics (BBLG) Share-based Compensation (2014 - 2025)
Bone Biologics (BBLG) reported Share-based Compensation of $45674.0 for Q4 2025, down 54.67% year-over-year from $100754.0 in Q4 2024, and down 47.61% quarter-over-quarter from $87180.0 in Q3 2025.
Bone Biologics (BBLG) Share-based Compensation (2014 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 10 years of Share-based Compensation data on file, last reported at $45674.0 in Q4 2025.
- Share-based Compensation for Q4 2025 came in at $45674.0, down 54.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $256358.0 (up 35.77% YoY), and the FY2025 annual result was $256358.0, up 35.77% from the prior year.
- Share-based Compensation fell to $45674.0 in Q4 2025 per BBLG's latest filing, from $87180.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $152844.0 in Q1 2022 and troughed at $16670.0 in Q2 2023.
- A 4-year average of $54025.6 and a median of $48139.5 in 2025 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation tumbled 70.71% in 2023, then surged 385.93% in 2025.
- A 4-year view of Share-based Compensation shows it stood at $62507.0 in 2022, then increased by 13.81% to $71139.0 in 2023, then surged by 41.63% to $100754.0 in 2024, then sank by 54.67% to $45674.0 in 2025.
- Business Quant data shows BBLG's Share-based Compensation at $45674.0 in Q4 2025, $87180.0 in Q3 2025, and $72899.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 26.47 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 45,674.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45,674.00 |
| Dec 31, 2025 | 45,674.00 |
| Sep 30, 2025 | 87,180.00 |
| Sep 30, 2025 | 87,180.00 |
| Jun 30, 2025 | 72,899.00 |
| Jun 30, 2025 | 72,899.00 |
| Mar 31, 2025 | 50,605.00 |
| Mar 31, 2025 | 50,605.00 |
| Dec 31, 2024 | 100,754.00 |
| Dec 31, 2024 | 100,754.00 |
| Sep 30, 2024 | 17,941.00 |
| Sep 30, 2024 | 17,941.00 |
| Jun 30, 2024 | 17,443.00 |
| Jun 30, 2024 | 17,443.00 |
| Mar 31, 2024 | 52,681.00 |
| Mar 31, 2024 | 52,681.00 |
| Dec 31, 2023 | 71,139.00 |
| Dec 31, 2023 | 71,139.00 |
| Sep 30, 2023 | 20,026.00 |
| Sep 30, 2023 | 20,026.00 |